UPC
Universe Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$3.98
+0.00 (+0.00%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 683.1K | 677.4K | 654.6K |
| Net Income | 91.4K | 91.7K | 101.2K |
| EPS | — | — | — |
| Profit Margin | 13.4% | 13.5% | 15.5% |
| Rev Growth | +6.4% | +6.4% | -8.3% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 163.0K | 155.8K | 159.5K |
| Total Equity | 1.10M | 1.13M | 1.17M |
| D/E Ratio | 0.15 | 0.14 | 0.14 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 144.9K | 139.8K | 143.9K |
| Free Cash Flow | 99.4K | 93.2K | 84.6K |